Cholera: Clinical Trials

9 trials for Cholera, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 1 recruiting, 1 unknown. 9 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 49Completed 7, Recruiting 1, Unknown 1

Follow Cholera: new trials by email Literature Review of Cholera trials Research Report on Cholera

Trials (filtered) newest first · largest first

All 9 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Extended Dosing Intervals Trial for Oral Cholera Vaccine, Kenya
Euvichol-S Oral Cholera Vaccine - Cholera Vaccination
Phase 4RecruitingAlbert B. Sabin Vaccine Institute10712025-10-312026-03-23
Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines
Oral typhoid fever vaccine, Oral cholera vaccine - Vaccine-Preventable Diseases, Typhoid Fever
Phase 4CompletedHelsinki University Central Hospital652023-10-252024-12-05
Immune Response to a Delayed Second Dose of Oral Cholera Vaccine
Delayed second dose of oral cholera vaccine, Euvichol-Plus, Oral cholera vaccine, Euvichol-Plus, according to manufacturer notice - Cholera, Vibrio Cholerae Infection
Phase 4UnknownEpicentre4562022-07-202023-03-07
Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine
Oral Cholera Vaccine, Adjusted Dose Oral Cholera Vaccine - Cholera, Vibrio Cholerae Infection
Phase 4CompletedJohns Hopkins Bloomberg School of Public Health1202017-11-162021-04-05
VAXCHORA Pediatric Study to Assess Safety and Immunogenicity
VAXCHORA (Cholera Vaccine, Live, Oral), Placebo - Cholera (Disorder)
Phase 4CompletedBavarian Nordic5502017-07-212023-06-28
A Study of Two Doses of Oral Cholera Vaccine (Shanchol™) in Subjects Aged 1 Year and Older in the Philippines
Shanchol™: Oral Cholera Vaccine Killed Bivalent (O1 and O139) Whole Cell - Cholera
Phase 4CompletedSanofi Pasteur, a Sanofi Company3362014-03-012018-03-23
Bridging Study for Killed Oral Cholera Vaccine in Ethiopia
Killed Bivalent (O1 and O139) whole cell oral cholera vaccine, Placebo - Vibrio Cholerae, Cholera
Phase 4CompletedInternational Vaccine Institute2162012-12-012015-05-04
Evaluation of a Boosting Regimen With Oral Cholera Vaccine
Shanchol™, oral cholera vaccine, Shanchol™, killed, whole cell, bivalent, oral cholera vaccine, no intervention - Cholera
Phase 4CompletedSachin Desai4262012-12-012013-09-25
A Study to Evaluate Safety and Immunogenicity of the Bivalent Killed Whole Cell Oral Cholera Vaccine in Adults and Children
killed bivalent (O1 and O139)whole cell oral cholera vaccine - Vibrio Cholerae
Phase 4CompletedInternational Vaccine Institute2002012-03-012014-06-17

Narrower conditions

Typhoid Fever (1)  ·  Vaccine-Preventable Diseases (1)

Broader conditions

Bacterial Infections (9)  ·  Bacterial Infections and Mycoses (9)  ·  Gram-Negative Bacterial Infections (9)  ·  Infections (9)  ·  Vibrio Infections (9)  ·  Enterobacteriaceae Infections (1)  ·  Salmonella Infections (1)

Interventions

Cholera Vaccines (5)  ·  shanchol (4)  ·  Dukoral (1)  ·  Ty21a typhoid vaccine (1)  ·  Vaxchora (1)

Sponsors

International Vaccine Institute (2)  ·  Albert B. Sabin Vaccine Institute (1)  ·  Bavarian Nordic (1)  ·  Epicentre (1)  ·  Helsinki University Central Hospital (1)  ·  Johns Hopkins Bloomberg School of Public Health (1)  ·  Sachin Desai (1)  ·  Sanofi Pasteur, a Sanofi Company (1)

Countries

India (2)  ·  Ethiopia (1)  ·  Finland (1)  ·  Guinea (1)  ·  Kenya (1)  ·  Philippines (1)  ·  United States (1)  ·  Zambia (1)

Top investigators

Amanda K Debes, PhD (1)  ·  Anu Kantele, MD, PhD (1)  ·  Paul Andre de Lame, MD (1)  ·  Suman Kanungo, MBBS (1)  ·  Venkata R Mohan, M.D., MPH (1)

Results publications

PMID 26078323, PMID 28910563, PMID 31211792, PMID 31769402, PMID 34217572